Outset Medical, Inc. (OM) stock
OMNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3068% below fair value
$3.86−0.31 (-7.43%)
Close on Nov 12, 2026Market cap $72.56MP/E –Yield –
Outset Medical gross margin
Gross margin is gross profit as a percentage of revenue.
Outset Medical's gross margin for the twelve months ending Sep 30, 2026 was 42.0%. For fiscal 2025 it was 39.1%, against 33.9% the year before. The highest annual figure on record is 39.1% in fiscal 2025.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 39.1% | +5.2 |
| FY2024 | Dec 31, 2024 | 33.9% | +11.7 |
| FY2023 | Dec 31, 2023 | 22.2% | +6.8 |
| FY2022 | Dec 31, 2022 | 15.5% | +8.0 |
| FY2021 | Dec 31, 2021 | 7.4% | +33.5 |
| FY2020 | Dec 31, 2020 | -26.1% | +92.0 |
| FY2019 | Dec 31, 2019 | -118.1% | +186.6 |
| FY2018 | Dec 31, 2018 | -304.7% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 40.7% | +1.3 |
| Q2 FY2026 | Jun 30, 2026 | 42.0% | +4.2 |
| Q1 FY2026 | Mar 31, 2026 | 43.4% | +6.2 |
| Q4 FY2025 | Dec 31, 2025 | 42.4% | +5.9 |
| Q3 FY2025 | Sep 30, 2025 | 39.4% | +5.1 |
| Q2 FY2025 | Jun 30, 2025 | 37.8% | +2.1 |
| Q1 FY2025 | Mar 31, 2025 | 37.2% | +8.0 |
| Q4 FY2024 | Dec 31, 2024 | 36.5% | +11.2 |
| Q3 FY2024 | Sep 30, 2024 | 34.3% | +10.7 |
| Q2 FY2024 | Jun 30, 2024 | 35.7% | +14.3 |
| Q1 FY2024 | Mar 31, 2024 | 29.2% | +10.0 |
| Q4 FY2023 | Dec 31, 2023 | 25.3% | +8.8 |
| Q3 FY2023 | Sep 30, 2023 | 23.6% | +8.0 |
| Q2 FY2023 | Jun 30, 2023 | 21.4% | +6.3 |
| Q1 FY2023 | Mar 31, 2023 | 19.2% | +4.7 |
| Q4 FY2022 | Dec 31, 2022 | 16.5% | +4.7 |
| Q3 FY2022 | Sep 30, 2022 | 15.6% | +4.4 |
| Q2 FY2022 | Jun 30, 2022 | 15.1% | +10.9 |
| Q1 FY2022 | Mar 31, 2022 | 14.5% | +13.3 |
| Q4 FY2021 | Dec 31, 2021 | 11.8% | +9.4 |
| Q3 FY2021 | Sep 30, 2021 | 11.2% | +48.5 |
| Q2 FY2021 | Jun 30, 2021 | 4.2% | +44.7 |
| Q1 FY2021 | Mar 31, 2021 | 1.3% | +50.8 |
| Q4 FY2020 | Dec 31, 2020 | 2.4% | +41.7 |
| Q3 FY2020 | Sep 30, 2020 | -37.3% | +164.0 |
| Q2 FY2020 | Jun 30, 2020 | -40.6% | +115.1 |
| Q1 FY2020 | Mar 31, 2020 | -49.6% | +161.5 |
| Q4 FY2019 | Dec 31, 2019 | -39.2% | – |
| Q3 FY2019 | Sep 30, 2019 | -201.3% | – |
| Q2 FY2019 | Jun 30, 2019 | -155.6% | – |
| Q1 FY2019 | Mar 31, 2019 | -211.1% | – |
See a number that looks wrong?